AL
AMJ

Aspiriant LLC’s JP Morgan Alerian MLP Index ETN 5/24/24 AMJ Stock Holding History

Aspiriant LLC’s Portfolio AMJ Stock Details AMJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,547
Closed -$314K – 214
2019
Q3 		$314K Sell
13,547
-20,840
-61% -$503K 0.03% 174
2019
Q2 		$862K Sell
34,387
-30,664
-47% -$772K 0.07% 121
2019
Q1 		$1.66M Sell
65,051
-30,914
-32% -$772K 0.14% 86
2018
Q4 		$2.14M Buy
95,965
+72,670
+312% +$1.84M 0.16% 77
2018
Q3 		$640K Sell
23,295
-3,927
-14% -$110K 0.05% 139
2018
Q2 		$724K Sell
27,222
-1,025
-4% -$26.8K 0.06% 132
2018
Q1 		$678K Buy
28,247
+14,101
+100% +$386K 0.06% 130
2017
Q4 		$389K Sell
14,146
-55,554
-80% -$1.51M 0.11% 56
2017
Q3 		$1.97M Buy
69,700
+379
+0.5% +$10.9K 0.16% 77
2017
Q2 		$2.06M Sell
69,321
-24,929
-26% -$766K 0.18% 78
2017
Q1 		$3.04M Buy
94,250
+2,020
+2% +$66K 0.26% 64
2016
Q4 		$2.92M Buy
92,230
+11,088
+14% +$339K 0.26% 54
2016
Q3 		$2.56M Sell
81,142
-76,548
-49% -$2.41M 0.25% 57
2016
Q2 		$5.02M Buy
157,690
+67,607
+75% +$2.01M 0.47% 36
2016
Q1 		$2.44M Buy
90,083
+5,205
+6% +$131K 0.23% 62
2015
Q4 		$2.46M Sell
84,878
-90,963
-52% -$2.79M 0.27% 31
2015
Q3 		$5.34M Sell
175,841
-13,538
-7% -$487K 0.44% 25
2015
Q2 		$7.5M Buy
189,379
+1,046
+0.6% +$45.4K 0.73% 16
2015
Q1 		$8.06M Buy
188,333
+72,071
+62% +$3.18M 1.05% 13
2014
Q4 		$5.34M Buy
116,262
+174
+0.1% +$8.51K 0.71% 18
2014
Q3 		$6.16M Sell
116,088
-1,886
-2% -$98.8K 0.86% 13
2014
Q2 		$6.18M Sell
117,974
-1,819
-2% -$89.6K 0.85% 13
2014
Q1 		$5.58M Buy
119,793
+28,670
+31% +$1.32M 0.81% 13
2013
Q4 		$4.22M Buy
+91,123
New +$4.11M 0.66% 14
2013
Q3 		– Sell
-70,903
Closed -$3.31M – 65
2013
Q2 		$3.31M Buy
+70,903
New +$3.28M 0.52% 16

Other funds holding AMJ

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Aspiriant LLC's AMJ Position: Q4 2019 in Review

Aspiriant LLC sold out of JP Morgan Alerian MLP Index ETN 5/24/24 (AMJ) in Q4 2019, closing a stake of 13,547 shares — an estimated $314K sold.

Aspiriant LLC first reported a position in AMJ in Q2 2013 and held it in 25 quarters. The position peaked at $8.06M in Q1 2015. 278 funds tracked by Wall St. Rank hold AMJ as of Q4 2019.

  • Aspiriant LLC reported no remaining JP Morgan Alerian MLP Index ETN 5/24/24 position as of Q4 2019 after selling out during the quarter.
  • Aspiriant LLC sold 13,547 JP Morgan Alerian MLP Index ETN 5/24/24 shares in Q4 2019, an estimated $314K.
  • Aspiriant LLC first reported a position in JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2013 and held it in 25 quarters.
  • Aspiriant LLC's JP Morgan Alerian MLP Index ETN 5/24/24 position peaked at $8.06M in Q1 2015.
  • 278 funds tracked by Wall St. Rank held JP Morgan Alerian MLP Index ETN 5/24/24 as of Q4 2019.

Based on Aspiriant LLC's 13F filing for Q4 2019, filed 27 Jan 2020.